Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Endothelial IGFBP6 Suppresses Vascular Inflammation and Atherosclerosis

ABSTRACT: Endothelial IGFBP6 Suppresses Vascular Inflammation and Atherosclerosis

PROVIDER: PRJNA1104204 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR28796158_1.fastq.gz	Fastqsanger.gz
	SRR28796158_2.fastq.gz	Fastqsanger.gz
	SRR28796159_1.fastq.gz	Fastqsanger.gz
	SRR28796159_2.fastq.gz	Fastqsanger.gz
	SRR28796160_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 18

Similar Datasets

Endothelial IGFBP6 Suppresses Vascular Inflammation and Atherosclerosis

Project description:It has previously been reported that expression levels of insulin-like growth factor binding protein 6 (IGFBP6) are reduced in unstable plaques compared to stable plaques in patients with coronary heart disease (CAD). However, the exact role and mechanism of IGFBP6 in endothelial homeostasis and inhibition of focal atherosclerotic plaque development in vivo remains unclear. Transcripome sequencing and bioinformatics analysis of IGFBP6-overexpressed human umbilical vein endothelial cells (HUVECs) suggest that pathway analysis and differentially expressed mRNA may help clarify the role and potential mechanism of IGFBP6 in the treatment of cardiovascular diseases.

2024-05-01 | GSE265787 | GEO

Endothelial TGFb signaling drives vascular inflammation and atherosclerosis

Project description:Endothelial TGFb signaling drives vascular inflammation and atherosclerosis

| PRJNA555585 | ENA

Endothelial TGFβ signaling drives vascular inflammation and atherosclerosis [scRNA-Seq]

Project description:Endothelial TGFβ signaling is one of the primary drivers of atherosclerosis-associated vascular inflammation. Inhibition of endothelial TGFβ signaling in hyperlipidemic mice reduces vessel wall inflammation and vascular permeability and leads to arrest of disease progression and regression of established lesions. We performed scRNAseq method to examine endothelial cell gene expression profile using Apoe and EC specific TGFbR1/2 KO in Apoe background mice.

2019-08-26 | GSE134557 | GEO

Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [ChIP-Seq]

2019-08-26 | GSE134556 | GEO

Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq]

2019-08-26 | GSE134555 | GEO

Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [ChIP-Seq]

Project description:Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [ChIP-Seq]

| PRJNA555593 | ENA

Endothelial TGFβ signaling drives vascular inflammation and atherosclerosis [scRNA-Seq]

Project description:Endothelial TGFβ signaling drives vascular inflammation and atherosclerosis [scRNA-Seq]

| PRJNA555594 | ENA

Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq]

Project description:Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq]

| PRJNA555592 | ENA

Ligustilide targets SMAD3, obstructing vascular fibrosis process in preventing atherosclerosis

Project description:Atherosclerosis is a persistent inflammatory state accompanied by lipid overload. Vascular fibrosis is one of the primary causes of atherosclerosis development. Although ligustilide (Lig) was shown to exert obvious antiatherogenic effects in previous studies, its precise mechanism has not been comprehensively discussed. In this paper, pharmacologic studies were performed to explore the pharmacodynamic effects of Lig on protecting aorta vascular wall structures and modulating serum inflammatory factors in ApoE-/- mice. Chemical proteomics based on a Lig-derived photoaffinity labelling (Lig-PAL) probe were applied to identify potential therapeutic targets. Mothers against decapentaplegic homologue 3 (SMAD3), which is closely related to the development of vascular fibrosis and atherosclerosis, was identified as a potential target of Lig. Lig suppressed the phosphorylation and nuclear translocation of SMAD3 by blocking the interaction between SMAD3 and transforming growth factor-β (TGF-β) receptor 1, thereby inhibiting the collagen synthesis process, preventing vascular fibrosis and improving atherosclerosis. The quantitative proteomics results from Lig-treated atherosclerotic ApoE-/- mice also indicated that Lig inhibits the expression of collagens I and III, interferes with collagen fibril organization processes and protects the aorta from vascular fibrosis. Hence, developing a novel SMAD3 inhibitor may present another therapeutic option for preventing atherosclerosis.

2020-01-21 | PXD017125 | Pride

Itaconate suppresses atherosclerosis by impeding inflammation through Nrf2 signaling

Project description:Itaconate suppresses atherosclerosis by impeding inflammation through Nrf2 signaling

| PRJNA987560 | ENA